FDA advisory panel reviewing COVID-19 vaccines in kids 5 and under
The FDA's vaccine advisory panel is meeting today to vote on Pfizer and Moderna's COVID-19 shots for children 5 and under. That same committee voted Tuesday to endorse Moderna's shot for kids ages 6 to 17. CBS News medical contributor Dr. David Agus explains what parents need to know before the FDA and CDC give their final approval.